{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:10Z","timestamp":1786984990088,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbamcr.2025.120076","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:58:03Z","timestamp":1762124283000},"page":"120076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["EZH2-mediated hypermethylation of H3K27me3 downregulates claudin-4 and upregulates the Wnt\/\u03b2-catenin signaling pathway in hepatocellular carcinoma metastasis"],"prefix":"10.1016","volume":"1873","author":[{"given":"Smriti","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-3860","authenticated-orcid":false,"given":"Madhav Nilakanth","family":"Mugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbamcr.2025.120076_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.45525","article-title":"Trends in hepatocellular carcinoma mortality rates in the US and projections THROUGH 2040","volume":"7","author":"Qiu","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120076_bb0010","doi-asserted-by":"crossref","first-page":"W658","DOI":"10.2214\/AJR.10.6402","article-title":"Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings","volume":"197","author":"Sneag","year":"2011","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hepr.13438","article-title":"Report of the 20th nationwide follow-up survey of primary liver cancer in Japan","volume":"50","author":"Kudo","year":"2020","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/liv.15051","article-title":"Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects","volume":"42","author":"Woo","year":"2022","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120076_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.gendis.2019.12.008","article-title":"Study on the hepatocellular carcinoma model with metastasis","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120076_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbamcr.2025.120076_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cancergen.2020.04.077","article-title":"High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1alpha (HIF-1alpha) predict patients\u2019 worse prognosis in human hepatocellular carcinomas","volume":"245","author":"Qian","year":"2020","journal-title":"Cancer Genet."},{"issue":"10","key":"10.1016\/j.bbamcr.2025.120076_bb0040","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1541-7786.MCR-14-0034","article-title":"EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma","volume":"12","author":"Gao","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-023-02855-2","article-title":"EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.120076_bb0050","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjc.6602531","article-title":"Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma","volume":"92","author":"Sudo","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbamcr.2025.120076_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242191","article-title":"EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma","volume":"15","author":"Guo","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120076_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2016.09.055","article-title":"EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3","volume":"479","author":"Luo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","article-title":"EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation","volume":"34","author":"Zingg","year":"2018","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bbamcr.2025.120076_bb0070","first-page":"868","article-title":"EZH2-mediated microRNA-139-5p regulates epithelial-mesenchymal transition and lymph node metastasis of pancreatic cancer","volume":"41","author":"Ma","year":"2018","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000101049","article-title":"Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis","volume":"74","author":"Ueda","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.bbamcr.2025.120076_bb0080","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2147\/OTT.S134813","article-title":"Role of matrix metalloproteinase-9 in transforming growth factor-beta1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma","volume":"10","author":"Bai","year":"2017","journal-title":"Onco. Targets. Ther."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120076_bb0085","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2896","article-title":"Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients","volume":"13","author":"Kallergi","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"5\u20136","key":"10.1016\/j.bbamcr.2025.120076_bb0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","article-title":"Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links","volume":"22","author":"Scheel","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jmb.2008.04.076","article-title":"Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form","volume":"383","author":"Pathuri","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bbamcr.2025.120076_bb0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/ijc.22850","article-title":"Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer","volume":"121","author":"Cabezon","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120076_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 enhances protumor macrophage polarization by control of PPAR-gamma-dependent induction of fatty acid oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"34","key":"10.1016\/j.bbamcr.2025.120076_bb0110","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1038\/sj.onc.1204636","article-title":"The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor","volume":"20","author":"Ambartsumian","year":"2001","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120076_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120076_bb0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/CCO.0000000000000390","article-title":"Targeting EZH2 in cancer therapy","volume":"29","author":"Yamagishi","year":"2017","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010093","article-title":"Solid Lipid Particles for Lung Metastasis Treatment","volume":"13","author":"Valdivia","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6907","key":"10.1016\/j.bbamcr.2025.120076_bb0130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2025.120076_bb0135","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4236\/jct.2013.42A051","article-title":"Animal Model of Lung Metastasis of Hepatocellular Carcinoma: A Tool for the Development of Anti-Metastatic Therapeutics","volume":"04","author":"Futakuchi","year":"2013","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2025.120076_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155810","article-title":"Corrigendum to \"Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma\" [Metabolism, Volume 152, March 2024, 155771]","volume":"153","author":"Ishteyaque","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0145","first-page":"57","article-title":"Serological diagnosis of liver metastasis in patients with breast cancer","volume":"9","author":"Cao","year":"2012","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13277-013-1141-0","article-title":"Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbamcr.2025.120076_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109701","article-title":"CYP2E1 triggered GRP78\/ATF6\/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma","volume":"745","author":"Ishteyaque","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"issue":"18","key":"10.1016\/j.bbamcr.2025.120076_bb0160","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.ejca.2010.07.046","article-title":"Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome","volume":"46","author":"Jensen","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120076_bb0165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/carcin\/bgw036","article-title":"CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma","volume":"37","author":"Li","year":"2016","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120076_bb0170","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2016.02.038","article-title":"Corrigendum to \u201cAlternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma\u201d [J Hepatol 2015;62:607-616]","volume":"64","author":"Yeung","year":"2016","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120076_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12253-008-9031-2","article-title":"Different expression of occludin and ZO-1 in primary and metastatic liver tumors","volume":"14","author":"Orban","year":"2008","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120076_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13148-023-01593-8","article-title":"Tazemetostat decreases \u03b2-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability","volume":"15","author":"Amin","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120076_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051569","article-title":"Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer","volume":"15","author":"Bekric","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bbamcr.2025.120076_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-024-07198-0","article-title":"Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma","volume":"15","author":"Lee","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bbamcr.2025.120076_bb0195","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:08:13Z","timestamp":1773313693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0167488925001818"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120076","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EZH2-mediated hypermethylation of H3K27me3 downregulates claudin-4 and upregulates the Wnt\/\u03b2-catenin signaling pathway in hepatocellular carcinoma metastasis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120076"}}